Sep 23 2019
The 46-year-old Chicago resident, who had recently started a mobile dog-grooming business, drove himself to a local community hospital after work, after experiencing swelling and pain in his leg and shortness of breath. An ultrasound of his left leg was performed, and he was diagnosed with a deep vein thrombosis (DVT), and a Chest CT showed a massive pulmonary saddle embolus with near complete occlusion of the right pulmonary artery as well as left-sided emboli. The man was started on standard IV heparin therapy in the ER and transferred to the ICU. Two days later, despite the fact that he was sub-therapeutic on the standard doses of heparin, he was switched to Lovenox (a heparin-based anti-coagulant at standard doses) and transferred from ICU to a general medical floor. The following day, the patient died as a result of another pulmonary embolism, which the plaintiff alleged would have been prevented by appropriate treatment for the known pulmonary embolism and DVT. The man was survived by his wife, 3 adult children, and a daughter born just 3 weeks prior to his death.